These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antinociceptive mechanism of the spirocyclopiperazinium compound LXM-10 in mice and rats. Xiong Y, Zhao X, Sun Q, Li R, Li C, Ye J. Pharmacol Biochem Behav; 2010 Apr; 95(2):192-7. PubMed ID: 20100504 [Abstract] [Full Text] [Related]
4. Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting α7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKIIα/CREB/CGRP signaling pathway in mice. Wan D, Wang D, Sun Q, Song Y, Jiang Y, Li R, Ye J. Eur J Pharmacol; 2016 Jan 05; 770():92-8. PubMed ID: 26658370 [Abstract] [Full Text] [Related]
5. Anti-inflammatory effect of the spirocyclopiperazinium compound LXM-10 in mice and rats. Xiong Y, Ye J, Sun Q, Zhao X, Li R, Jiang Y. Eur J Pharmacol; 2010 Jan 25; 626(2-3):290-6. PubMed ID: 19836382 [Abstract] [Full Text] [Related]
6. Mechanisms involved in the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis (lemon balm) in mice. Guginski G, Luiz AP, Silva MD, Massaro M, Martins DF, Chaves J, Mattos RW, Silveira D, Ferreira VM, Calixto JB, Santos AR. Pharmacol Biochem Behav; 2009 Jul 25; 93(1):10-6. PubMed ID: 19358864 [Abstract] [Full Text] [Related]
7. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice. Anjaneyulu M, Chopra K. Eur J Pharmacol; 2006 May 24; 538(1-3):80-4. PubMed ID: 16650402 [Abstract] [Full Text] [Related]
8. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist. Damaj MI, Glassco W, Aceto MD, Martin BR. J Pharmacol Exp Ther; 1999 Oct 24; 291(1):390-8. PubMed ID: 10490929 [Abstract] [Full Text] [Related]
9. Antinociceptive effects of choline against acute and inflammatory pain. Wang Y, Su DM, Wang RH, Liu Y, Wang H. Neuroscience; 2005 Oct 24; 132(1):49-56. PubMed ID: 15780465 [Abstract] [Full Text] [Related]
16. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats. Hamurtekin E, Bagdas D, Gurun MS. Neurosci Lett; 2007 Jun 13; 420(2):116-21. PubMed ID: 17531379 [Abstract] [Full Text] [Related]
17. Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice. Yang H, Sun Q, Liang Y, Jiang Y, Li R, Ye J. Regul Toxicol Pharmacol; 2018 Apr 13; 94():108-114. PubMed ID: 29353067 [Abstract] [Full Text] [Related]
18. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene. Ozdoğan UK, Lähdesmäki J, Scheinin M. Eur J Pharmacol; 2006 Jan 04; 529(1-3):105-13. PubMed ID: 16325800 [Abstract] [Full Text] [Related]
19. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Decker MW, Bannon AW, Buckley MJ, Kim DJ, Holladay MW, Ryther KB, Lin NH, Wasicak JT, Williams M, Arneric SP. Eur J Pharmacol; 1998 Apr 03; 346(1):23-33. PubMed ID: 9617748 [Abstract] [Full Text] [Related]
20. Antinociceptive effect of the Orbignya speciosa Mart. (Babassu) leaves: evidence for the involvement of apigenin. Pinheiro MM, Boylan F, Fernandes PD. Life Sci; 2012 Sep 24; 91(9-10):293-300. PubMed ID: 22749864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]